Lumexa Imaging Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Lumexa Imaging Holdings, Inc. (LMRI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $12.74 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- Lumexa Imaging Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $12.74M, a 52.61% increase year-over-year.
- Lumexa Imaging Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $12.27M, a 92.56% increase year-over-year.
- Lumexa Imaging Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $8.35M.
- Lumexa Imaging Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $6.37M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month |
|---|---|---|
| 2026-06-30 | $12.74M 10-Q · filed 2026-08-13 | $25.01M derived: sum of 2 quarters · filed 2026-08-13 |
| 2026-03-31 | $12.27M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $8.35M 10-Q · filed 2026-08-13 | $14.72M derived: sum of 2 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.37M 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B |